ADIPOQ and benign prostatic hyperplasia: Figure 1B-1D show correlations between serum adiponectin levels and TPV in all subjects (r=-0.618, p<0.001), control subjects (r=-0.499, p<0.001) and BPH patients (r=-0.575, p<0.001).